Matches in Wikidata for { <http://www.wikidata.org/entity/Q66079853> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q66079853 description "clinical trial" @default.
- Q66079853 description "ensayu clínicu" @default.
- Q66079853 description "klinisch onderzoek" @default.
- Q66079853 description "клінічне випробування" @default.
- Q66079853 description "կլինիկական փորձարկում" @default.
- Q66079853 name "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse" @default.
- Q66079853 name "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse" @default.
- Q66079853 type Item @default.
- Q66079853 label "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse" @default.
- Q66079853 label "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse" @default.
- Q66079853 prefLabel "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse" @default.
- Q66079853 prefLabel "hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse" @default.
- Q66079853 P1132 Q66079853-94BAEFA2-D50E-4AA5-879B-3B0FF4788EED @default.
- Q66079853 P1476 Q66079853-E2493E65-71E3-43F0-A9F8-59248B755766 @default.
- Q66079853 P17 Q66079853-F984D5BD-87C4-420A-AAE3-DC3666A08D14 @default.
- Q66079853 P1813 Q66079853-80D78AA6-44F6-4077-86BD-A0B3B6D7AF37 @default.
- Q66079853 P2899 Q66079853-15A6ED4F-550A-45D3-8B09-FE6E724862FD @default.
- Q66079853 P3098 Q66079853-69A9CA7F-8FD1-4CEF-8CBD-D22D57701305 @default.
- Q66079853 P31 Q66079853-A0083A80-73B1-4988-BDED-F2035AB4D04C @default.
- Q66079853 P580 Q66079853-1E7EE171-8068-40F3-93FA-3A3CE425F604 @default.
- Q66079853 P582 Q66079853-48559E39-F9CE-464D-AB78-321ED4369F23 @default.
- Q66079853 P6099 Q66079853-8A44B97B-CE52-4B2C-A4F1-89CF6CC8CE5E @default.
- Q66079853 P6153 Q66079853-409728B9-D22A-4AF9-B32E-1B040C2BBD72 @default.
- Q66079853 P6153 Q66079853-7BC764DB-D05E-49C7-ACF3-8321D4C8DC9E @default.
- Q66079853 P6153 Q66079853-AFE87BFF-8472-44C6-8449-E3F828C6B07E @default.
- Q66079853 P6153 Q66079853-BF3D06AE-BCE9-4A0E-A165-CA0C016BE2C6 @default.
- Q66079853 P767 Q66079853-398322DD-B4D7-469A-A770-61000E8F51D1 @default.
- Q66079853 P8363 Q66079853-7DF141DD-800B-4346-9B7B-589D3852ACE4 @default.
- Q66079853 P921 Q66079853-C240B751-4E98-46A1-9581-D2B6B3681073 @default.
- Q66079853 P1132 "+93" @default.
- Q66079853 P1476 "A Multi-center Study of hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Post Definitive Surgery and Standard Therapy" @default.
- Q66079853 P17 Q30 @default.
- Q66079853 P1813 "TRT-001" @default.
- Q66079853 P2899 "+18" @default.
- Q66079853 P3098 "NCT02960594" @default.
- Q66079853 P31 Q30612 @default.
- Q66079853 P580 "2014-12-01T00:00:00Z" @default.
- Q66079853 P582 "2018-11-09T00:00:00Z" @default.
- Q66079853 P6099 Q5452194 @default.
- Q66079853 P6153 Q1130172 @default.
- Q66079853 P6153 Q235034 @default.
- Q66079853 P6153 Q4858714 @default.
- Q66079853 P6153 Q49117 @default.
- Q66079853 P767 Q1191202 @default.
- Q66079853 P8363 Q78089383 @default.
- Q66079853 P921 Q128581 @default.